These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 22788786

  • 1. Formulation development and optimization of bilayer tablets of aceclofenac.
    Dey S, Mahanti B, Khila S, Mazumder B, Gupta SD.
    Expert Opin Drug Deliv; 2012 Sep; 9(9):1041-50. PubMed ID: 22788786
    [Abstract] [Full Text] [Related]

  • 2. Chitosan and enteric polymer based once daily sustained release tablets of aceclofenac: in vitro and in vivo studies.
    Mutalik S, Manoj K, Reddy MS, Kushtagi P, Usha AN, Anju P, Ranjith AK, Udupa N.
    AAPS PharmSciTech; 2008 Sep; 9(2):651-9. PubMed ID: 18500561
    [Abstract] [Full Text] [Related]

  • 3. Preparation, in vitro, preclinical and clinical evaluations of once daily sustained release tablets of aceclofenac.
    Mutalik S, Naha A, Usha AN, Ranjith AK, Musmade P, Manoj K, Anju P, Prasanna S.
    Arch Pharm Res; 2007 Feb; 30(2):222-34. PubMed ID: 17366745
    [Abstract] [Full Text] [Related]

  • 4. [Effect of release of hydroxypropylmethyl cellulose on single and bilayer sustained-release matrix tablets].
    Yang YP, Wang MY, Chang JB, Guo MT.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr 18; 45(2):291-6. PubMed ID: 23591354
    [Abstract] [Full Text] [Related]

  • 5. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
    Kang WH, Nguyen HV, Park C, Choi YW, Lee BJ.
    Eur J Pharm Sci; 2017 May 01; 102():85-93. PubMed ID: 28263912
    [Abstract] [Full Text] [Related]

  • 6. Dual release and molecular mechanism of bilayered aceclofenac tablet using polymer mixture.
    Van Nguyen H, Nguyen VH, Lee BJ.
    Int J Pharm; 2016 Dec 30; 515(1-2):233-244. PubMed ID: 27744034
    [Abstract] [Full Text] [Related]

  • 7. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A, Ozkan Y, Işimer A.
    Farmaco; 2005 Feb 30; 60(2):171-7. PubMed ID: 15752476
    [Abstract] [Full Text] [Related]

  • 8. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM, Abdel-Rahman AA, Ahmed SM, Alanazi FK, Habib WA, Sakr A.
    Acta Pol Pharm; 2016 Feb 30; 73(2):439-52. PubMed ID: 27180437
    [Abstract] [Full Text] [Related]

  • 9. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH, Taha NF, Badr RM, Mursi NM.
    Drug Discov Ther; 2012 Oct 30; 6(5):269-77. PubMed ID: 23229148
    [Abstract] [Full Text] [Related]

  • 10. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA, Lamas MC, Salamón CJ.
    J Pharm Pharm Sci; 2002 Oct 30; 5(3):213-9. PubMed ID: 12553888
    [Abstract] [Full Text] [Related]

  • 11. [Study of sustained-matrix tablets Ambroxol hydrochloride and potential impact of different fillers on the matrix tablet's scale-up].
    Wang MY, Yang YP, Chang JB, Guo MT.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct 18; 44(5):742-8. PubMed ID: 23073585
    [Abstract] [Full Text] [Related]

  • 12. Effects of drug solubility on the release kinetics of water soluble and insoluble drugs from HPMC based matrix formulations.
    Chakraborty S, Khandai M, Sharma A, Patra ChN, Patro VJ, Sen KK.
    Acta Pharm; 2009 Sep 18; 59(3):313-23. PubMed ID: 19819827
    [Abstract] [Full Text] [Related]

  • 13. In vitro determination of aceclofenac Mouth Dissolving Tablets.
    Shobhit S, Gupta SK.
    Polim Med; 2013 Sep 18; 43(4):227-9. PubMed ID: 24596037
    [Abstract] [Full Text] [Related]

  • 14. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F, Ford JL, Rubinstein MH, Rajabi-Siahboomi AR.
    Drug Dev Ind Pharm; 2000 Jun 18; 26(6):651-60. PubMed ID: 10826113
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of drug release in citrate buffered HPMC matrices.
    Pygall SR, Kujawinski S, Timmins P, Melia CD.
    Int J Pharm; 2009 Mar 31; 370(1-2):110-20. PubMed ID: 19100822
    [Abstract] [Full Text] [Related]

  • 16. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction.
    Hariharan M, Wowchuk C, Nkansah P, Gupta VK.
    Drug Dev Ind Pharm; 2004 Jul 31; 30(6):565-72. PubMed ID: 15285329
    [Abstract] [Full Text] [Related]

  • 17. Aceclofenac fast dispersible tablet formulations: Effect of different concentration levels of Avicel PH102 on the compactional, mechanical and drug release characteristics.
    Yasmin R, Shoaib MH, Ahmed FR, Qazi F, Ali H, Zafar F.
    PLoS One; 2020 Jul 31; 15(2):e0223201. PubMed ID: 32050259
    [Abstract] [Full Text] [Related]

  • 18. The performance of HPMC matrix tablets using various agglomeration manufacturing processes.
    Košir D, Vrečer F.
    Drug Dev Ind Pharm; 2017 Feb 31; 43(2):329-337. PubMed ID: 27739880
    [Abstract] [Full Text] [Related]

  • 19. New comprehensive mathematical model for HPMC-MCC based matrices to design oral controlled release systems.
    Saeidipour F, Mansourpour Z, Mortazavian E, Rafiee-Tehrani N, Rafiee-Tehrani M.
    Eur J Pharm Biopharm; 2017 Dec 31; 121():61-72. PubMed ID: 28951063
    [Abstract] [Full Text] [Related]

  • 20. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D, Sailaja Chirravuri SV, Shastri NR.
    Int J Pharm; 2014 Jan 30; 461(1-2):459-68. PubMed ID: 24368106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.